Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV.

about

Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis.

P2860

Q49452570-28A89549-C9A5-4B63-BEE1-7C05BA972715

P2860

Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV.

Item

http://www.wikidata.org/entity/Q40039541

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Fingolimod induces neuronal-sp ...... ogenitor cells exposed to HIV.

@en

type

Item

label

Fingolimod induces neuronal-sp ...... ogenitor cells exposed to HIV.

@en

prefLabel

Fingolimod induces neuronal-sp ...... ogenitor cells exposed to HIV.

@en

P1476

Fingolimod induces neuronal-sp ...... ogenitor cells exposed to HIV.

@en

P2093

Alicia de Las Pozas

http://www.w3.org/2001/XMLSchema#string

Biju Issac

http://www.w3.org/2001/XMLSchema#string

Micheline McCarthy

http://www.w3.org/2001/XMLSchema#string

Rebeca Geffin

http://www.w3.org/2001/XMLSchema#string

Ricardo Martinez

http://www.w3.org/2001/XMLSchema#string

P2860

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy

HIV and aging: effects on the central nervous system

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

Fingolimod phosphate attenuates oligomeric amyloid β-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neurons

Alzheimer's disease

Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10.

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.

A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease.

The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment.

P2888

s13365-017-0571-7

P304

808-824

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13365-017-0571-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28913617

http://www.w3.org/2001/XMLSchema#string

P932

5725524

http://www.w3.org/2001/XMLSchema#string

Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV.

about

P2860

P2860

Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932